July 29, 2025
DKSH has entered a partnership with PacBio, a leading developer of sequencing solutions, to distribute their products in Australia. Following the successful collaboration in other markets, DKSH will expand access to their genomic sequencing solutions for the Australian scientific community. Sydney, Australia – DKSH, a leading Market Expansion Services provider, has entered into an exclusive [...]
Concept Life Sciences & Fios Genomics Partner to Enhance Complex Data Analysis in Drug Discovery
July 29, 2025
Strategic alliance based in the Edinburgh BioQuarter provides clients with richer data analysis, driving smarter, data-driven decisions Chapel-en-le-Frith & Edinburgh, United Kingdom – Concept Life Sciences, a leading contract research organisation (CRO) serving the global life sciences industry, today announced a strategic partnership with Edinburgh-based Fios Genomics, a leading bioinformatics provider serving clients globally. The partnership [...]
Bio-Rad Appoints Rajat Mehta Executive Vice President, Global Commercial Operations
July 28, 2025
HERCULES, Calif. -- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the appointment of Rajat Mehta as its new Executive Vice President, Global Commercial Operations, effective August 4, 2025. Mehta will lead Bio-Rad's global commercial strategy and execution, succeeding Mike Crowley, who is [...]
Danaher, IGI, CZI Unite for CRISPR Breakthroughs
July 28, 2025
Sadik Kassim, Danaher CTO for Genomic Medicines and Vanessa Almendro, Danaher Head of Science & Technology Innovation discuss how the work developing a ‘CRISPR Cookbook’ will support the new Center for Pediatric CRISPR Cures. Danaher is proud to provide the essential manufacturing infrastructure for the new Center for Pediatric CRISPR Cures, launched by the Chan Zuckerberg Initiative and [...]
Thermo Fisher Scientific’s Chief Financial Officer, Stephen Williamson, to Retire in Early 2026
July 28, 2025
Jim Meyer to Become Chief Financial Officer, Effective March 1, 2026 WALTHAM, Mass. -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that Stephen Williamson, senior vice president and chief financial officer (CFO), has decided to retire from the company, effective March 31, 2026. The company’s board of directors [...]
Pluristyx Completes Investment Round to Expand Product Portfolio and Commercial Operations
July 28, 2025
SEATTLE -- Pluristyx, a leading provider of induced pluripotent stem cell (iPSC) technologies and proprietary gene editing solutions, today announced the successful close of its most recent round of funding led by BioLife Solutions, the global leader in cryopreservation technologies and systems that support cell and gene therapy (CGT) manufacturing, and BroadOak Capital Partners, a [...]
July 28, 2025
Malvern Panalytical is proud to announce it is now an Associate Member of the International Pharmaceutical Aerosol Consortium on Regulation & Science (IPAC-RS) – an association that advances the science and regulatory standards of orally inhaled and nasal drug products (OINDPs) through collaboration, research, and development. This strategic partnership underpins Malvern Panalytical’s commitment to innovation [...]
Pluristyx Completes Investment Round to Expand Product Portfolio and Commercial Operations
July 28, 2025
eattle, Washington – Pluristyx, a leading provider of induced pluripotent stem cell (iPSC) technologies and proprietary gene editing solutions, today announced the successful close of its most recent round of funding led by BioLife Solutions, the global leader in cryopreservation technologies and systems that support cell and gene therapy (CGT) manufacturing, and BroadOak Capital Partners, [...]
July 25, 2025
WOBURN, Mass. -- Spear Bio, a biotechnology company pioneering homogeneous ultrasensitive immunoassay technology, today announced the commercial launch of its SPEAR UltraDetect™ immunoassay solution. It delivers unparalleled sensitivity, specificity, precision, and scalability for robust biomarker measurement. The initial launch includes four assays, targeting key neurology biomarkers: phosphorylated tau 231 (pTau231), phosphorylated tau 217 (pTau217), glial [...]
MilliporeSigma and Washington University in St. Louis Sign MoU to Advance Scientific Collaboration
July 24, 2025
Strengthens 90-year legacy of partnership between MilliporeSigma and WashU to accelerate scientific progress Strategic academic-industry alliance aims to build robust Research & Development talent pipeline Reinforces Mill ST. LOUIS — MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, has signed a non-binding Memorandum of [...]

